Low-sodium oxybate reduces 24-hour sleep duration and daytime napping in adults with idiopathic hypersomnia, according to a phase 3 trial analysis.
Professor Johan Verbraecken, shares insights on a recent ERS consensus statement on advanced telemedicine in obstructive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results